In connection with the implementation of the project titled „Design and development of an innovative solution – a complex, three-component medicinal product targeting the treatment of hypertension”, financed from the state budget funds from the Medical Research Agency, Zakłady Farmaceutyczne „Polpharma” S.A., requests for offers to conduct a clinical phase IV study.
Details of the price inquiry can be found in the documents attached below.